Bernard Pécoul Selected Research

Proteins (Proteins, Gene)

1/2021

Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernard Pécoul Research Topics

Disease

2	Neglected Diseases 12/2013 - 12/2010
1	Chronic Hepatitis C 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Coinfection 01/2021
1	Infections 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Cardiotoxicity 10/2018
1	Visceral Leishmaniasis (Kala Azar) 10/2018
1	Persistent Infection 12/2010

Drug/Important Bio-Agent (IBA)

1	ravidasvirIBA 01/2021
1	InterferonsIBA 01/2021
1	SofosbuvirIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	miltefosine (Impavido)IBA 10/2018
1	liposomal amphotericin B FDA Link 10/2018
1	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 10/2018
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 10/2018
1	VaccinesIBA 12/2013
1	4-nitroimidazoleIBA 12/2010
1	fexinidazoleIBA 12/2010

Therapy/Procedure

1	Injections 10/2018
1	Therapeutics 10/2018
1	Oral Administration 12/2010